Latvia vs Libya: Share of the population living with HIV receiving antiretroviral therapy
Latvia
52.4%
in 2024
Libya
50.4%
in 2023
Latvia rank
122nd
Libya rank
125th
Share of the population living with HIV receiving antiretroviral therapy over time
- Latvia
- Libya
How they compare
Latvia currently reports 52.4% against 50.4% in Libya, a difference of 2.0%.
The two have swapped places 1 time across 34 shared years of data; in 1990 it was Libya ahead.
Latvia ranks 122nd and Libya ranks 125th of 149 countries.
Across the 4 decades both report, Latvia averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Latvia | Libya | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0% | 0.0% | 0.0% | — |
| 2000s | 3.2% | 21.0% | 17.8% | Libya |
| 2010s | 22.0% | 55.4% | 33.4% | Libya |
| 2020s | 49.4% | 49.0% | 0.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of the population living with hiv receiving antiretroviral therapy, Latvia or Libya?
- Latvia, at 52.4% against 50.4% in Libya as of 2024.
- What is the difference in share of the population living with hiv receiving antiretroviral therapy between Latvia and Libya?
- 2.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Libya?
- 34 years are reported by both, from 1990 to 2023.
- How do Latvia and Libya rank globally for share of the population living with hiv receiving antiretroviral therapy?
- Latvia ranks 122nd and Libya ranks 125th of 149 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as Share of the population living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.